Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Adalimumab in Psoriasis: How Much Is Enough?

Billi AC, Gudjonsson JE.

J Invest Dermatol. 2019 Jan;139(1):19-22. doi: 10.1016/j.jid.2018.08.012.

PMID:
30579425
2.

Phospholipase C-β1 interacts with cyclin E in adipose- derived stem cells osteogenic differentiation.

Ramazzotti G, Fiume R, Chiarini F, Campana G, Ratti S, Billi AM, Manzoli L, Follo MY, Suh PG, McCubrey J, Cocco L, Faenza I.

Adv Biol Regul. 2018 Nov 5. pii: S2212-4926(18)30152-0. doi: 10.1016/j.jbior.2018.11.001. [Epub ahead of print]

PMID:
30420274
3.

Sex bias in autoimmunity.

Billi AC, Kahlenberg JM, Gudjonsson JE.

Curr Opin Rheumatol. 2019 Jan;31(1):53-61. doi: 10.1097/BOR.0000000000000564.

PMID:
30394940
4.

Endoscopic endonasal approach to primitive Meckel's cave tumors: a clinical series.

Zoli M, Ratti S, Guaraldi F, Milanese L, Pasquini E, Frank G, Billi AM, Manzoli L, Cocco L, Mazzatenta D.

Acta Neurochir (Wien). 2018 Dec;160(12):2349-2361. doi: 10.1007/s00701-018-3708-4. Epub 2018 Oct 31.

PMID:
30382359
5.

Nuclear inositide signaling and cell cycle.

Ratti S, Ramazzotti G, Faenza I, Fiume R, Mongiorgi S, Billi AM, McCubrey JA, Suh PG, Manzoli L, Cocco L, Follo MY.

Adv Biol Regul. 2018 Jan;67:1-6. doi: 10.1016/j.jbior.2017.10.008. Epub 2017 Oct 23. Review.

PMID:
29102395
6.

Hydrogeochemical changes before and during the 2016 Amatrice-Norcia seismic sequence (central Italy).

Barberio MD, Barbieri M, Billi A, Doglioni C, Petitta M.

Sci Rep. 2017 Sep 15;7(1):11735. doi: 10.1038/s41598-017-11990-8.

7.

Ultra-thin clay layers facilitate seismic slip in carbonate faults.

Smeraglia L, Billi A, Carminati E, Cavallo A, Di Toro G, Spagnuolo E, Zorzi F.

Sci Rep. 2017 Apr 6;7(1):664. doi: 10.1038/s41598-017-00717-4.

8.

PLC-β1 and cell differentiation: An insight into myogenesis and osteogenesis.

Ramazzotti G, Faenza I, Fiume R, Billi AM, Manzoli L, Mongiorgi S, Ratti S, McCubrey JA, Suh PG, Cocco L, Follo MY.

Adv Biol Regul. 2017 Jan;63:1-5. doi: 10.1016/j.jbior.2016.10.005. Epub 2016 Oct 18. Review.

PMID:
27776973
9.

IPMK and β-catenin mediate PLC-β1-dependent signaling in myogenic differentiation.

Ramazzotti G, Billi AM, Manzoli L, Mazzetti C, Ruggeri A, Erneux C, Kim S, Suh PG, Cocco L, Faenza I.

Oncotarget. 2016 Dec 20;7(51):84118-84127. doi: 10.18632/oncotarget.11527.

10.

Endoscopic endonasal anatomy of the ophthalmic artery in the optic canal.

Zoli M, Manzoli L, Bonfatti R, Ruggeri A, Mariani GA, Bacci A, Sturiale C, Pasquini E, Billi AM, Frank G, Cocco L, Mazzatenta D.

Acta Neurochir (Wien). 2016 Jul;158(7):1343-50. doi: 10.1007/s00701-016-2797-1. Epub 2016 Apr 27.

PMID:
27117907
11.

Selective Activation of Nuclear PI-PLCbeta1 During Normal and Therapy-Related Differentiation.

Mongiorgi S, Follo MY, Yang YR, Ratti S, Manzoli L, McCubrey JA, Billi AM, Suh PG, Cocco L.

Curr Pharm Des. 2016;22(16):2345-8. Review.

PMID:
26916022
12.

Nuclear Phosphatidylinositol Signaling: Focus on Phosphatidylinositol Phosphate Kinases and Phospholipases C.

Poli A, Billi AM, Mongiorgi S, Ratti S, McCubrey JA, Suh PG, Cocco L, Ramazzotti G.

J Cell Physiol. 2016 Aug;231(8):1645-55. doi: 10.1002/jcp.25273. Epub 2015 Dec 28. Review.

PMID:
26626942
13.

Inositide-dependent signaling pathways as new therapeutic targets in myelodysplastic syndromes.

Mongiorgi S, Finelli C, Yang YR, Clissa C, McCubrey JA, Billi AM, Manzoli L, Suh PG, Cocco L, Follo MY.

Expert Opin Ther Targets. 2016 Jun;20(6):677-87. doi: 10.1517/14728222.2016.1125885. Epub 2015 Dec 17. Review.

PMID:
26610046
14.

An increased expression of PI-PLCβ1 is associated with myeloid differentiation and a longer response to azacitidine in myelodysplastic syndromes.

Cocco L, Finelli C, Mongiorgi S, Clissa C, Russo D, Bosi C, Quaranta M, Malagola M, Parisi S, Stanzani M, Ramazzotti G, Mariani GA, Billi AM, Manzoli L, Follo MY.

J Leukoc Biol. 2015 Nov;98(5):769-80. doi: 10.1189/jlb.2MA1114-541R. Epub 2015 May 14.

PMID:
25977289
15.

Strategic Role of Nuclear Inositide Signalling in Myelodysplastic Syndromes Therapy.

Manzoli L, Mongiorgi S, Clissa C, Finelli C, Billi AM, Poli A, Quaranta M, Cocco L, Follo MY.

Mini Rev Med Chem. 2014 Oct 13. [Epub ahead of print]

PMID:
25307310
16.

Endogenous RNAi pathways in C. elegans.

Billi AC, Fischer SE, Kim JK.

WormBook. 2014 May 7:1-49. doi: 10.1895/wormbook.1.170.1. Review.

17.

A conserved upstream motif orchestrates autonomous, germline-enriched expression of Caenorhabditis elegans piRNAs.

Billi AC, Freeberg MA, Day AM, Chun SY, Khivansara V, Kim JK.

PLoS Genet. 2013;9(3):e1003392. doi: 10.1371/journal.pgen.1003392. Epub 2013 Mar 14.

18.

Identification of small RNA pathway genes using patterns of phylogenetic conservation and divergence.

Tabach Y, Billi AC, Hayes GD, Newman MA, Zuk O, Gabel H, Kamath R, Yacoby K, Chapman B, Garcia SM, Borowsky M, Kim JK, Ruvkun G.

Nature. 2013 Jan 31;493(7434):694-8. doi: 10.1038/nature11779. Epub 2012 Dec 23.

19.

Hepato-gastric and spleno-mesenteric arterial trunks: anatomical variation report and review of literature.

Mariani GA, Maroni L, Bianchi L, Broccoli A, Lazzarini E, Marchegiani G, Mazzotti A, Mazzotti MC, Billi AM, Piccari GG, Cocco L, Manzoli L.

Ital J Anat Embryol. 2013;118(2):217-22. Review.

PMID:
25338412
20.

piRNAs and siRNAs collaborate in Caenorhabditis elegans genome defense.

Billi AC, Freeberg MA, Kim JK.

Genome Biol. 2012 Jul 20;13(7):164. doi: 10.1186/gb-2012-13-7-164.

21.

Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies.

Martelli AM, Chiarini F, Evangelisti C, Ognibene A, Bressanin D, Billi AM, Manzoli L, Cappellini A, McCubrey JA.

Expert Opin Ther Targets. 2012 Jul;16(7):729-42. doi: 10.1517/14728222.2012.694869. Epub 2012 Jun 12. Review.

PMID:
22686561
22.

MORC family ATPases required for heterochromatin condensation and gene silencing.

Moissiard G, Cokus SJ, Cary J, Feng S, Billi AC, Stroud H, Husmann D, Zhan Y, Lajoie BR, McCord RP, Hale CJ, Feng W, Michaels SD, Frand AR, Pellegrini M, Dekker J, Kim JK, Jacobsen SE.

Science. 2012 Jun 15;336(6087):1448-51. doi: 10.1126/science.1221472. Epub 2012 May 3.

23.

The Caenorhabditis elegans HEN1 ortholog, HENN-1, methylates and stabilizes select subclasses of germline small RNAs.

Billi AC, Alessi AF, Khivansara V, Han T, Freeberg M, Mitani S, Kim JK.

PLoS Genet. 2012;8(4):e1002617. doi: 10.1371/journal.pgen.1002617. Epub 2012 Apr 19.

24.

Nuclear PLCs affect insulin secretion by targeting PPARγ in pancreatic β cells.

Fiume R, Ramazzotti G, Faenza I, Piazzi M, Bavelloni A, Billi AM, Cocco L.

FASEB J. 2012 Jan;26(1):203-10. doi: 10.1096/fj.11-186510. Epub 2011 Oct 5.

PMID:
21974932
25.

GABAergic and glutamatergic identities of developing midbrain Pitx2 neurons.

Waite MR, Skidmore JM, Billi AC, Martin JF, Martin DM.

Dev Dyn. 2011 Feb;240(2):333-46. doi: 10.1002/dvdy.22532. Epub 2011 Jan 11.

26.

The phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin signaling network and the control of normal myelopoiesis.

Martelli AM, Chiarini F, Evangelisti C, Grimaldi C, Ognibene A, Manzoli L, Billi AM, McCubrey JA.

Histol Histopathol. 2010 May;25(5):669-80. doi: 10.14670/HH-25.669. Review.

PMID:
20238304
27.

Identification of a functional nuclear export sequence in diacylglycerol kinase-zeta.

Evangelisti C, Gaboardi GC, Billi AM, Ognibene A, Goto K, Tazzari PL, McCubrey JA, Martelli AM.

Cell Cycle. 2010 Jan 15;9(2):384-8. Epub 2010 Jan 29.

PMID:
20023381
28.

A role for PKCepsilon during C2C12 myogenic differentiation.

Gaboardi GC, Ramazzotti G, Bavelloni A, Piazzi M, Fiume R, Billi AM, Matteucci A, Faenza I, Cocco L.

Cell Signal. 2010 Apr;22(4):629-35. doi: 10.1016/j.cellsig.2009.11.017. Epub 2009 Nov 29.

PMID:
19954762
29.

Inositide signaling in the nucleus: from physiology to pathology.

Cocco L, Follo MY, Faenza I, Billi AM, Ramazzotti G, Martelli AM, Manzoli L, Weber G.

Adv Enzyme Regul. 2010;50(1):2-11. doi: 10.1016/j.advenzreg.2009.10.007. Epub 2009 Nov 4. Review. No abstract available.

PMID:
19895834
30.

Nuclear inositides: PI-PLC signaling in cell growth, differentiation and pathology.

Cocco L, Faenza I, Follo MY, Billi AM, Ramazzotti G, Papa V, Martelli AM, Manzoli L.

Adv Enzyme Regul. 2009;49(1):2-10. doi: 10.1016/j.advenzreg.2008.12.001. Epub 2008 Dec 31. Review. No abstract available.

PMID:
19159640
31.

Involvement of nuclear PLCbeta1 in lamin B1 phosphorylation and G2/M cell cycle progression.

Fiume R, Ramazzotti G, Teti G, Chiarini F, Faenza I, Mazzotti G, Billi AM, Cocco L.

FASEB J. 2009 Mar;23(3):957-66. doi: 10.1096/fj.08-121244. Epub 2008 Nov 21.

PMID:
19028838
32.

Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes.

Cocco L, Faenza I, Follo MY, Ramazzotti G, Gaboardi GC, Billi AM, Martelli AM, Manzoli L.

Adv Enzyme Regul. 2008;48:2-9. doi: 10.1016/j.advenzreg.2007.11.013. Epub 2008 Mar 17. Review. No abstract available.

PMID:
18280812
33.

Nuclear phospholipase C beta1 and cellular differentiation.

Faenza I, Bregoli L, Ramazzotti G, Gaboardi G, Follo MY, Mongiorgi S, Billi AM, Manzoli L, Martelli AM, Cocco L.

Front Biosci. 2008 Jan 1;13:2452-63. Review.

PMID:
17981726
34.

Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells.

Papa V, Tazzari PL, Chiarini F, Cappellini A, Ricci F, Billi AM, Evangelisti C, Ottaviani E, Martinelli G, Testoni N, McCubrey JA, Martelli AM.

Leukemia. 2008 Jan;22(1):147-60. Epub 2007 Oct 11.

PMID:
17928881
35.

Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside.

Martelli AM, Tazzari PL, Evangelisti C, Chiarini F, Blalock WL, Billi AM, Manzoli L, McCubrey JA, Cocco L.

Curr Med Chem. 2007;14(19):2009-23. Review.

PMID:
17691943
36.

Evidence for a direct role of the disease modifier SCNM1 in splicing.

Howell VM, Jones JM, Bergren SK, Li L, Billi AC, Avenarius MR, Meisler MH.

Hum Mol Genet. 2007 Oct 15;16(20):2506-16. Epub 2007 Jul 26.

PMID:
17656373
37.

Intranuclear 3'-phosphoinositide metabolism and apoptosis protection in PC12 cells.

Martelli AM, Evangelist C, Billi AM, Manzoli L, Papa V, Cocco L.

Acta Biomed. 2007;78 Suppl 1:113-9.

PMID:
17465329
38.

Nuclear inositide signaling: an appraisal of phospholipase C beta 1 behavior in myelodysplastic and leukemia cells.

Cocco L, Follo MY, Faenza I, Bavelloni A, Billi AM, Martelli AM, Manzoli L.

Adv Enzyme Regul. 2007;47:2-9. Epub 2007 Mar 1. Review. No abstract available.

PMID:
17335878
39.

Expression of phosphoinositide-specific phospholipase C isoenzymes in cultured astrocytes.

Lo Vasco VR, Fabrizi C, Artico M, Cocco L, Billi AM, Fumagalli L, Manzoli FA.

J Cell Biochem. 2007 Mar 1;100(4):952-9.

PMID:
17063484
40.

Signal transduction within the nucleus: revisiting phosphoinositide inositide-specific phospholipase Cbeta1.

Cocco L, Martelli AM, Fiume R, Faenza I, Billi AM, Manzoli FA.

Adv Enzyme Regul. 2006;46:2-11. Epub 2006 Jul 18. Review. No abstract available.

PMID:
16846636
41.

Intranuclear 3'-phosphoinositide metabolism and Akt signaling: new mechanisms for tumorigenesis and protection against apoptosis?

Martelli AM, Faenza I, Billi AM, Manzoli L, Evangelisti C, Falà F, Cocco L.

Cell Signal. 2006 Aug;18(8):1101-7. Epub 2006 Mar 3. Review.

PMID:
16516442
42.

Nuclear phospholipase C signaling through type 1 IGF receptor and its involvement in cell growth and differentiation.

Faenza I, Billi AM, Follo MY, Fiume R, Martelli AM, Cocco L, Manzoli L.

Anticancer Res. 2005 May-Jun;25(3B):2039-41. Review.

43.

Phosphoinositide 3-kinase/Akt inhibition increases arsenic trioxide-induced apoptosis of acute promyelocytic and T-cell leukaemias.

Tabellini G, Tazzari PL, Bortul R, Evangelisti C, Billi AM, Grafone T, Martinelli G, Baccarani M, Martelli AM.

Br J Haematol. 2005 Sep;130(5):716-25.

PMID:
16115127
44.

Nuclear inositol lipid metabolism: more than just second messenger generation?

Martelli AM, Follo MY, Evangelisti C, Falà F, Fiume R, Billi AM, Cocco L.

J Cell Biochem. 2005 Oct 1;96(2):285-92. Review.

PMID:
16088939
45.

Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway.

Bortul R, Tazzari PL, Billi AM, Tabellini G, Mantovani I, Cappellini A, Grafone T, Martinelli G, Conte R, Martelli AM.

Br J Haematol. 2005 Jun;129(5):677-86.

PMID:
15916691
46.

Nuclear phospholipase C: involvement in signal transduction.

Manzoli L, Martelli AM, Billi AM, Faenza I, Fiume R, Cocco L.

Prog Lipid Res. 2005 Jul;44(4):185-206. Epub 2005 Apr 26. Review.

PMID:
15896848
47.

Genetic interaction between Wnt7a and Lrp6 during patterning of dorsal and posterior structures of the mouse limb.

Adamska M, Billi AC, Cheek S, Meisler MH.

Dev Dyn. 2005 Jun;233(2):368-72. Erratum in: Dev Dyn. 2005 Aug;233(4):1614.

48.

Antiapoptotic role of p38 mitogen activated protein kinase in Jurkat T cells and normal human T lymphocytes treated with 8-methoxypsoralen and ultraviolet-A radiation.

Cappellini A, Tazzari PL, Mantovani I, Billi AM, Tassi C, Ricci F, Conte R, Martelli AM.

Apoptosis. 2005 Jan;10(1):141-52.

PMID:
15711930
49.

Involvement of the phosphoinositide 3-kinase/Akt signaling pathway in the resistance to therapeutic treatments of human leukemias.

Martelli AM, Tabellini G, Bortul R, Tazzari PL, Cappellini A, Billi AM, Cocco L.

Histol Histopathol. 2005 Jan;20(1):239-52. doi: 10.14670/HH-20.239. Review.

PMID:
15578442
50.

Nuclear diacylglycerol kinase-theta is activated in response to nerve growth factor stimulation of PC12 cells.

Tabellini G, Billi AM, Falà F, Cappellini A, Evagelisti C, Manzoli L, Cocco L, Martelli AM.

Cell Signal. 2004 Nov;16(11):1263-71.

PMID:
15337525

Supplemental Content

Support Center